A systematic review of the value assessment frameworks used within health technology assessment of Omics technologies and their actual adoption from HTA agencies
Publication typeJournal article with impact factor
Van Dyck, Walter
JournalInternational Journal of Environmental Research and Public Health
MetadataShow full item record
AbstractBackground: Omics technologies, enabling the measurements of genes (genomics), mRNA (transcriptomics), proteins (proteomics) and metabolites (metabolomics), are valuable tools for personalized decision-making. We aimed to identify the existing value assessment frameworks used by health technology assessment (HTA) doers for the evaluation of omics technologies through a systematic review. Methods: PubMed, Scopus, Embase and Web of Science databases were searched to retrieve potential eligible articles published until 31 May 2020 in English. Additionally, through a desk research in HTA agencies' repositories, we retrieved the published reports on the practical use of these frameworks. Results: Twenty-three articles were included in the systematic review. Twenty-two frameworks, which addressed genetic and/or genomic technologies, were described. Most of them derived from the ACCE framework and evaluated the domains of analytical validity, clinical validity and clinical utility. We retrieved forty-five reports, which mainly addressed the commercial transcriptomic prognostics and next generation sequencing, and evaluated clinical effectiveness, economic aspects, and description and technical characteristics. Conclusions: A value assessment framework for the HTA evaluation of omics technologies is not standardized and accepted, yet. Our work reports that the most evaluated domains are analytical validity, clinical validity and clinical utility and economic aspects.
KeywordGenomics, Health Technology Assessment, Metabolomics, Omics Sciences, Omics Technologies, Personalized Medicine, Proteomics, Transcriptomics, Value Assessment Frameworks
Knowledge Domain/IndustryOperations & Supply Chain Management
Special Industries : Healthcare Management
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- EVIDENCE REQUIRED BY HEALTH TECHNOLGY ASSESSMENT AND REIMBURSEMENT BODIES EVALUATING DIAGNOSTIC OR PROGNOSTIC ALGORITHMS THAT INCLUDE OMICS DATA.
- Authors: Barna A, Cruz-Sanchez TM, Brigham KB, Thuong CT, Kristensen FB, Durand-Zaleski I
- Issue date: 2018 Jan
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
- Authors: Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P
- Issue date: 2022 Feb 1
- A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies.
- Authors: Ibargoyen-Roteta N, Galnares-Cordero L, Benguria-Arrate G, Chacón-Acevedo KR, Gutiérrez-Sepulveda MP, Low-Padilla E, De La Hoz-Siegler IH, Guevara-Pérez CI, Del Pozo-Pérez Á, Suárez M, Dauben HP, Otte M, Gutiérrez-Ibarluzea I
- Issue date: 2022
- SUITABILITY OF CURRENT EVALUATION FRAMEWORKS FOR USE IN THE HEALTH TECHNOLOGY ASSESSMENT OF MOBILE MEDICAL APPLICATIONS: A SYSTEMATIC REVIEW.
- Authors: Moshi MR, Tooher R, Merlin T
- Issue date: 2018 Jan
- Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
- Authors: Calabrò GE, La Torre G, de Waure C, Villari P, Federici A, Ricciardi W, Specchia ML
- Issue date: 2018 Mar 1